ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

New Design For NCI’s CancerNet Wins Prestigious Web Site Design Awards.

November 17, 2000

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Of Smokers Screened With CT In Study, 7% Have Lung Cancer

December 31, 2004

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976